Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
Authors
Keywords
-
Journal
Pharmaceutics
Volume 11, Issue 7, Pages 315
Publisher
MDPI AG
Online
2019-07-04
DOI
10.3390/pharmaceutics11070315
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers
- (2019) Emily A. Krogstad et al. AIDS PATIENT CARE AND STDS
- Extended Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention
- (2018) Stephanie E. Barrett et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention
- (2018) Ariane van der Straten et al. Journal of the International AIDS Society
- Effect of Ionizing Radiation on the Chemical Structure and the Physical Properties of Polycaprolactones of Different Molecular Weight
- (2018) Rodrigo Navarro et al. Polymers
- Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis
- (2018) Corrine Ying Xuan Chua et al. JOURNAL OF CONTROLLED RELEASE
- Perspectives of South African youth in the development of an implant for HIV prevention
- (2018) Emily A Krogstad et al. Journal of the International AIDS Society
- Ultra-long-acting removable drug delivery system for HIV treatment and prevention
- (2018) Martina Kovarova et al. Nature Communications
- Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
- (2018) Raphael J. Landovitz et al. PLOS MEDICINE
- An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM
- (2017) Sybil G. Hosek et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
- (2017) Philip Grossen et al. JOURNAL OF CONTROLLED RELEASE
- Effect of plasma immersion ion implantation on polycaprolactone with various molecular weights and crystallinity
- (2017) Elena Kosobrodova et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States
- (2017) Sybil G. Hosek et al. JAMA Pediatrics
- Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
- (2017) Martin Markowitz et al. Lancet HIV
- 3D- Printed Poly(ε-caprolactone) Scaffold Integrated with Cell-laden Chitosan Hydrogels for Bone Tissue Engineering
- (2017) Liang Dong et al. Scientific Reports
- MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel
- (2016) Ross D. Cranston et al. CLINICAL INFECTIOUS DISEASES
- Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate
- (2016) Vijaya Madhyanapu Golla et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
- (2016) Sheena McCormack et al. LANCET
- Influence of therapeutic radiation on polycaprolactone and polyurethane biomaterials
- (2016) Shelley L. Cooke et al. Materials Science & Engineering C-Materials for Biological Applications
- A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis
- (2016) Erica Schlesinger et al. PHARMACEUTICAL RESEARCH
- Crystallization of poly(ε-caprolactone) in its immiscible blend with polylactide: insight into the role of annealing histories
- (2016) Qiaolian Lv et al. RSC Advances
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)
- (2015) Kerri J. Penrose et al. JOURNAL OF INFECTIOUS DISEASES
- Polycaprolactone thin-film drug delivery systems: Empirical and predictive models for device design
- (2015) Erica Schlesinger et al. Materials Science & Engineering C-Materials for Biological Applications
- Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
- (2015) Jeanne M. Marrazzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
- (2015) Jean-Michel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
- (2015) Madeline B Deutsch et al. Lancet HIV
- Towards the understanding of the molecular weight dependence of essential work of fracture in semi-crystalline polymers: A study on poly(ε-caprolactone)
- (2014) F. Tuba et al. Express Polymer Letters
- Characterization of the Polycaprolactone Melt Crystallization: Complementary Optical Microscopy, DSC, and AFM Studies
- (2014) V. Speranza et al. TheScientificWorldJOURNAL
- The polymer free volume as a controlling factor for drug release from poly(lactide-co-glycolide) microspheres
- (2013) Stefan Scheler JOURNAL OF APPLIED POLYMER SCIENCE
- Polymeric Modification and Its Implication in Drug Delivery: Poly-ε-caprolactone (PCL) as a Model Polymer
- (2012) Tapan K. Dash et al. MOLECULAR PHARMACEUTICS
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Prophylaxis for HIV Infection among African Women
- (2012) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights on the crystallization and melting of cyclic PCL chains on the basis of a modified Thomson–Gibbs equation
- (2012) Hsuan-Han Su et al. POLYMER
- Preparation of poly(ε-caprolactone)/poly(ε-caprolactone-co-lactide) (PCL/PLCL) blend filament by melt spinning
- (2011) Bhuvanesh Gupta et al. JOURNAL OF APPLIED POLYMER SCIENCE
- Resilon: a methacrylate resin-based obturation system
- (2010) Deepti Shrestha et al. Journal of Dental Sciences
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion
- (2010) Julia A. Haller et al. OPHTHALMOLOGY
- The return of a forgotten polymer—Polycaprolactone in the 21st century
- (2010) Maria Ann Woodruff et al. PROGRESS IN POLYMER SCIENCE
- Assessment of a disposable trocar for insertion of contraceptive implants
- (2009) Markus J. Steiner et al. CONTRACEPTION
- Dynamics ofin vitropolymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions
- (2008) Christopher X F Lam et al. Biomedical Materials
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started